Skip to main content
SANTEN PHARMACEUTICAL CO.,LTD. logo

SANTEN PHARMACEUTICAL CO.,LTD. — Investor Relations & Filings

Ticker · 4536 ISIN · JP3336000009 LEI · 529900TPT3I7C17MIM03 T Manufacturing
Open in API
Filings indexed 78 across all filing types
Latest filing 2022-08-08 Report Publication Anno…
Country JP Japan
Listing T 4536

About SANTEN PHARMACEUTICAL CO.,LTD.

https://www.santen.com/en

Santen Pharmaceutical Co., Ltd. is a global company specializing in ophthalmology. It is engaged in the research, development, manufacturing, sales, and marketing of pharmaceutical products and medical devices dedicated to eye health. The company's portfolio includes prescription and over-the-counter pharmaceuticals that address a wide range of ophthalmic conditions. Serving patients, consumers, and medical professionals in over 60 countries, Santen aims to contribute to the realization of “Happiness with Vision” by providing valuable products and services worldwide.

Recent filings

Filing Released Lang Actions
確認書
Report Publication Announcement Classification · 100% confidence The document is a 'Confirmation Letter' (Kakunin-sho) filed under the Financial Instruments and Exchange Act, specifically related to the 'First Quarter Report' (Dai-ichi shihanki hokokusho). It confirms the accuracy of the financial statements for the first quarter of the 111th fiscal period. Since this is a formal regulatory filing confirming the contents of a quarterly report rather than the quarterly report itself, and it does not fit into the specific categories for earnings releases or full reports, it is classified as a Regulatory Filing.
2022-08-08 Japanese
四半期報告書－第111期第1四半期(令和4年4月1日－令和4年6月30日)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) filed with the Kanto Local Finance Bureau in Japan. It contains detailed financial statements, management analysis (MDA), and operational data for the first quarter of the 111th fiscal period (April 1, 2022, to June 30, 2022). It is a comprehensive financial report rather than an announcement or a summary, fitting the definition of an Interim/Quarterly Report (IR). Q1 2022
2022-08-08 Japanese
確認書
Audit Report / Information Classification · 98% confidence The document is a 'Confirmation Letter' (Kakunin-sho) filed under the Financial Instruments and Exchange Act in Japan, which accompanies the Annual Securities Report (Yukashoken Hokokusho). It confirms the accuracy of the financial statements for the 110th fiscal period. Since it is a formal regulatory filing confirming the contents of a report rather than the report itself, and given the specific regulatory context, it falls under the RNS (Regulatory Filings) category. FY 2022
2022-06-24 Japanese
内部統制報告書－第110期(令和3年4月1日－令和4年3月31日)
Governance Information Classification · 100% confidence The document is an 'Internal Control Report' (内部統制報告書) filed under the Financial Instruments and Exchange Act (金融商品取引法) in Japan. This type of report details the company's internal control framework, evaluation scope, and effectiveness regarding financial reporting. It is a formal regulatory filing required by Japanese law, which falls under the 'Regulatory Filings' category as it does not fit into the specific financial report categories like 10-K or IR, but is a mandatory compliance document.
2022-06-24 Japanese
有価証券報告書－第110期(令和3年4月1日－令和4年3月31日)
Annual Report
2022-06-24 Japanese
四半期報告書－第110期第3四半期(令和3年10月1日－令和3年12月31日)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) for Santen Pharmaceutical Co., Ltd., covering the third quarter of the 110th fiscal year (period from October 1, 2021, to December 31, 2021). It contains detailed financial statements, management analysis (MDA), and business performance metrics, which aligns with the definition of an Interim/Quarterly Report (IR). 9M 2022
2022-02-14 Japanese

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.